Recent events
Recent events tied to this brand in public sources.
Back to profile4 entries
2026
Piramal Pharma completes acquisition of 40.67% incremental stake in Yapan Bio
Piramal Pharma Ltd. completed the acquisition of an incremental 40.67% stake in Hyderabad-based CDMO Yapan Bio Private Limited for an aggregate cash consideration of ₹76 crore ($7.95M), raising its ownership to 74% and making Yapan Bio a subsidiary.
2026
Piramal Pharma completes acquisition of controlling stake in Yapan Bio
Piramal Pharma Ltd. completed the acquisition of an incremental 40.67% stake in Yapan Bio Private Limited for an aggregate cash consideration of ₹76 crore ($7.95M USD), bringing its ownership to 74% and making Yapan Bio a subsidiary.
2021
Piramal Pharma completes acquisition of Hemmo Pharmaceuticals
Piramal Pharma completed its acquisition of Hemmo Pharmaceuticals, according to Piramal Enterprises.
2020
Carlyle acquires a 20% stake in Piramal Pharma
Carlyle acquired a 20% stake in Piramal Pharma for US$490 million (nearly Rs 3,700 crore). The deal was expected to close in 2020, with the final equity investment amount dependent on net debt, exchange rates and performance against pre-agreed conditions.